Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation
Author:
Affiliation:
1. Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
2. Department of Bioregulatory Science of Life-related Diseases, Fukuoka University, Fukuoka, Japan
3. Muta Hospital, Fukuoka, Japan
Funder
Japan Society for the Promotion of Science
Publisher
The Endocrine Society
Subject
Endocrinology
Link
http://academic.oup.com/endo/article-pdf/159/4/1774/24398532/en.2018-00099.pdf
Reference50 articles.
1. Cancer statistics, 2000;Greenlee;CA Cancer J Clin,2000
2. The androgen receptor: a potential target for therapy of prostate cancer;Santos;Steroids,2004
3. The decline of androgen levels in elderly men and its clinical and therapeutic implications;Kaufman;Endocr Rev,2005
4. Clinical review 171: the rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations;Liu;J Clin Endocrinol Metab,2004
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reflections and expectations of an endocrinologist and diabetologist on the launch of a new, board-certified Endocrinology, Diabetes and Metabolism specialist system pioneered by the JES and the JDS;Endocrine Journal;2024
2. In vitro anti-carcinogenic effect of andarine as a selective androgen receptor modulator on MIA-PaCa-2 cells by decreased proliferation and cell-cycle arrest at G0/G1 phase;Biochemical and Biophysical Research Communications;2023-09
3. Andarine Plays a Robust In-vitro Anti-carcinogenic Role on A549 Cells Through Inhibition of Proliferation and Migration, and Activation of Cell-cycle Arrest, Senescence, and Apoptosis;2023-04-06
4. In vitro metabolic studies of novel selective androgen receptor modulators and their use for doping control analysis;Drug Testing and Analysis;2021-09-07
5. Activation of overexpressed glucagon‐like peptide‐1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression;Journal of Diabetes Investigation;2020-04-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3